Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Kiniksa Pharmaceuticals International (KNSA) Return on Invested Capital (2021 - 2025)

Kiniksa Pharmaceuticals International (KNSA) has disclosed Return on Invested Capital for 5 consecutive years, with 0.11% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Invested Capital rose 21.0% year-over-year to 0.11%, compared with a TTM value of 0.11% through Dec 2025, up 21.0%, and an annual FY2025 reading of 0.12%, up 22.0% over the prior year.
  • Return on Invested Capital was 0.11% for Q4 2025 at Kiniksa Pharmaceuticals International, up from 0.07% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.51% in Q2 2023 and bottomed at 0.79% in Q4 2021.
  • Average Return on Invested Capital over 5 years is 0.04%, with a median of 0.04% recorded in 2024.
  • The sharpest move saw Return on Invested Capital surged 121bps in 2022, then crashed -55bps in 2024.
  • Year by year, Return on Invested Capital stood at 0.79% in 2021, then skyrocketed by 153bps to 0.42% in 2022, then crashed by -114bps to 0.06% in 2023, then tumbled by -77bps to 0.1% in 2024, then surged by 211bps to 0.11% in 2025.
  • Business Quant data shows Return on Invested Capital for KNSA at 0.11% in Q4 2025, 0.07% in Q3 2025, and 0.01% in Q2 2025.